Skip to content
CancerIndex

Loading the knowledge graph…

A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer — knowledge graph · CancerIndex